BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 31059077)

  • 1. Rab3B enhances the stabilization of DDX6 to promote lung adenocarcinoma aggressiveness.
    Yao G; Yu S; Hou F; Xiao Z; Li G; Ji X; Wang J
    Mol Med; 2024 Jun; 30(1):75. PubMed ID: 38834947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells.
    Filograna A; De Tito S; Monte ML; Oliva R; Bruzzese F; Roca MS; Zannetti A; Greco A; Spano D; Ayala I; Liberti A; Petraccone L; Dathan N; Catara G; Schembri L; Colanzi A; Budillon A; Beccari AR; Del Vecchio P; Luini A; Corda D; Valente C
    J Exp Clin Cancer Res; 2024 May; 43(1):137. PubMed ID: 38711119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced therapeutic effect of an antiangiogenesis peptide on lung cancer in vivo combined with salmonella VNP20009 carrying a Sox2 shRNA construct.
    Zhao C; He J; Cheng H; Zhu Z; Xu H
    J Exp Clin Cancer Res; 2016 Jul; 35(1):107. PubMed ID: 27371094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoglobin Subunit Theta 1 Promotes Proliferation by Reducing Reactive Oxygen Species in Lung Adenocarcinoma.
    Kim K; Choi EY; Ahn HM; Kim DG; Kim YJ
    Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction to "CtBP1 promotes tumour-associated macrophage infiltration and progression in non-small-cell lung cancer".
    J Cell Mol Med; 2024 May; 28(10):e18189. PubMed ID: 38770973
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin II Inhibits Adipogenic Differentiation and Promotes Mature Adipocyte Browning through the Corepressor CtBP1.
    Liang X; Sun J; Guan H; Zhu Q; Yao W
    Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36551887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTBP1 strengthens the cisplatin resistance of gastric cancer cells by upregulating RAD51 expression.
    Wu Y; Zhao H
    Oncol Lett; 2021 Nov; 22(5):810. PubMed ID: 34630717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of DERL3 Affecting the Proliferation, Invasion and Metastasis of Lung Adenocarcinoma A549 Cells].
    Zhou D; Wang J; Yang K; Zhang L; Zheng Q; Bai J; Hu Y; Mu Q; Yin C; Li H
    Zhongguo Fei Ai Za Zhi; 2020 Aug; 23(8):638-645. PubMed ID: 32838486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CtBP1 promotes tumour-associated macrophage infiltration and progression in non-small-cell lung cancer.
    Wang Z; Zhao Y; Xu H; Liang F; Zou Q; Wang C; Jiang J; Lin F
    J Cell Mol Med; 2020 Oct; 24(19):11445-11456. PubMed ID: 32910558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-195 suppresses the progression of lung adenocarcinoma by directly targeting apelin.
    Zhou Y; Zhao M; Du Y; Liu Y; Zhao G; Ye L; Li Q; Li H; Wang X; Liu X; Guo Y; Liu J; Huang Y
    Thorac Cancer; 2019 Jun; 10(6):1419-1430. PubMed ID: 31070305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CtBP1 interacts with SOX2 to promote the growth, migration and invasion of lung adenocarcinoma.
    Liu Y; Bian T; Feng J; Qian L; Li X; Zhang Q; Zhang J; Jiang D; Liu J; Shi J
    Oncol Rep; 2019 Jul; 42(1):67-78. PubMed ID: 31059077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of CUL4A on the metastatic potential of lung adenocarcinoma to the bone.
    Cao PP; Chen WJ; Pang HL; Shen WW; Xue P; Duan L; Xu YX; Liu LL; Zhang HL
    Oncol Rep; 2020 Feb; 43(2):662-670. PubMed ID: 31894344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma.
    Zhao CC; Chen J; Niu RF; Liu Y; Zhang CG
    Oncol Rep; 2018 Dec; 40(6):3392-3404. PubMed ID: 30272365
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.